Comparison

pf-04691502

Item no. V0123-500mg
Manufacturer InvivoChem LLC
CASRN 1013101-36-4
Amount 500mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V0123CAS #:1013101-36-4Purity >=98%

Description:PF-04691502 is a novel, potent, ATP-competitive and selective dual inhibitor of PI3K (phosphatidylinositol 3 kinase) and mTOR (mammalian target of rapamycin) with potential anticancer activity. It inhibits PI3K(alpha/beta/delta/gamma)/mTOR with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM in cell-free assays. PF04691502 shows little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. PF-04691502 is a potential anticancer agent that suppresses tumor growth in cancer cells overexpressing PI3K/mTOR.

Description:Description:

References: Mol Cancer Ther. 2011 Nov; 10(11):2189-99; Mol Cancer Ther. 2011 Aug; 10(8):1440-9.

References: References:
Molecular Weight (MW)
425.48
Formula
C22H27N5O4
CAS No.
1013101-36-4
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 14 mg/mL (32.9 mM)
Water:< 1 mg/mL
Ethanol: < 1 mg/mL
Synonym
PF-04691502; PF 04691502; PF04691502; PF 4691502; PF4691502; PF-4691502
Chemical Name
2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2, 3-d]pyrimidin-7-one

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close